Lefetamine
| Lefetamine | |
|---|---|
 |
| Salts [] | |
|---|---|
| Lefetamine hydrochloride | |
| Molecular structure via molpic based on CDK |
| Rotamer [] | |
|---|---|
| Conformer structure via 3Dmol.js |
| Physical properties [] | |
|---|---|
| Molecular mass | 225.33 g/mol [1] |
| Predicted LogP | 3.7 [1] |
| Structural Identifiers [] | |
|---|---|
| Molecular formula | C16H19N [1] |
| IUPAC name | (1R)-N,N-dimethyl-1,2-diphenylethanamine [1] |
| SMILES | CN(C)[C@H](CC1=CC=CC=C1)C2=CC=CC=C2 [1] |
| InChI | InChI=1S/C16H19N/c1-17(2)16(15-11-7-4-8-12-15)13-14-9-5-3-6-10-14/h3-12,16H,13H2,1-2H3/t16-/m1/s1 [1] |
| InChIKey | YEJZJVJJPVZXGX-MRXNPFEDSA-N [1] |
Lefetamine (also known as Lefetamina, Lephetamine, Lefetaminum, Dtxsid7046833, Dtxcid5026833, Santenol, lephetamine, hydrochloride, N,N-Dimethyl-1,2-diphenylethylamine, DEA No. 1635 or N,N-Dimethyl-1,2-diphenyl-ethylamine) is a
Chemistry
Salts []
Lefetamine is typically found in the form of its hydrochloride salt.
Stereochemistry []
Lefetamine is a absolute mixture.
Subjective effects []
Legal status []
- Australia: Lefetamine is a S4 substance.
- Brazil: Lefetamine is a B1 substance.[3]
- Canada: Lefetamine is a Schedule III substance.
- United States: Lefetamine is a Schedule I under the "Controlled Substances Act (CSA)".
- United Kingdom: Lefetamine is a Class B substance.
- Germany: Lefetamine is a Anlage I substance.
See also []
External links []
References []
National Center for Biotechnology Information. PubChem Compound Summary for CID 443970, Lefetamine. Accessed May 6, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/443970
U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Lefetamine. UNII: 4J9726V5Y9. Global Substance Registration System. Accessed May 6, 2026. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/4J9726V5Y9
Anvisa. RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial. Diário Oficial da União. March 31, 2023. Accessed May 6, 2026. https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-784-de-31-de-marco-de-2023-474904992